Publication | Open Access

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

HepatologyHepatitis CViral HepatitisProspective Observational StudyAntiviral TherapyHepatitisVirologyComplications Of CirrhosisLiver DiseaseAntiviral DrugMedicineEpidemiology